N. Ueda

857 total citations
23 papers, 722 citations indexed

About

N. Ueda is a scholar working on Infectious Diseases, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, N. Ueda has authored 23 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Psychiatry and Mental health. Recurrent topics in N. Ueda's work include HIV/AIDS drug development and treatment (5 papers), Schizophrenia research and treatment (4 papers) and HIV Research and Treatment (3 papers). N. Ueda is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Schizophrenia research and treatment (4 papers) and HIV Research and Treatment (3 papers). N. Ueda collaborates with scholars based in Japan, Sweden and Germany. N. Ueda's co-authors include Reiji Yoshimura, Jun Nakamura, Eleni Aklillu, Jürgen Burhenne, Walter E. Haefeli, Koji Shinkai, Akira Suda, K. Riedel, Takashi Uozumi and Akira Tamagawa and has published in prestigious journals such as Psychopharmacology, Clinical Pharmacology & Therapeutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

N. Ueda

23 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Ueda Japan	13	228	136	110	101	101	23	722
Kalyan Ghosh United States	8	285 1.3×	33 0.2×	43 0.4×	226 2.2×	90 0.9×	8	804
Sihong Huang China	15	112 0.5×	31 0.2×	25 0.2×	167 1.7×	38 0.4×	44	740
Daniel T. Barratt Australia	16	41 0.2×	212 1.6×	18 0.2×	99 1.0×	13 0.1×	34	952
Michael B. Tennison United States	20	85 0.4×	17 0.1×	37 0.3×	161 1.6×	20 0.2×	42	1.1k
Björn Ahl Germany	11	52 0.2×	26 0.2×	38 0.3×	47 0.5×	33 0.3×	14	860
Harpreet Kaur India	15	23 0.1×	53 0.4×	46 0.4×	116 1.1×	19 0.2×	47	545
Richard T. Moxley United States	16	91 0.4×	7 0.1×	93 0.8×	279 2.8×	143 1.4×	24	894
Paolo B. DePetrillo United States	14	82 0.4×	12 0.1×	27 0.2×	129 1.3×	13 0.1×	41	829
Antonia Wadley South Africa	15	85 0.4×	12 0.1×	14 0.1×	37 0.4×	161 1.6×	30	450
Jacinta Murray United States	14	100 0.4×	7 0.1×	11 0.1×	127 1.3×	211 2.1×	25	748

Countries citing papers authored by N. Ueda

Since Specialization

Citations

This map shows the geographic impact of N. Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Ueda more than expected).

Fields of papers citing papers by N. Ueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Ueda. The network helps show where N. Ueda may publish in the future.

Co-authorship network of co-authors of N. Ueda

This figure shows the co-authorship network connecting the top 25 collaborators of N. Ueda. A scholar is included among the top collaborators of N. Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Ueda. N. Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ngaimisi, Eliford, Omary Minzi, Sabina Mugusi, et al.. (2014). Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4 -hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment. Journal of Antimicrobial Chemotherapy. 69(12). 3311–3319. 24 indexed citations

Kaku, Kohei, Arihiro Kiyosue, Shin‐ichiro Inoue, et al.. (2014). Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise. Diabetes Obesity and Metabolism. 16(11). 1102–1110. 99 indexed citations

Haslemo, Tore, Irena Loryan, N. Ueda, et al.. (2012). UGT1A4*3 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems. Clinical Pharmacology & Therapeutics. 92(2). 221–227. 28 indexed citations

Habtewold, Abiy, Wondwossen Amogne, Eyasu Makonnen, et al.. (2011). Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients. Journal of Antimicrobial Chemotherapy. 66(10). 2350–2361. 52 indexed citations

Yimer, Getnet, Wondwossen Amogne, Abiy Habtewold, et al.. (2011). High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study. The Pharmacogenomics Journal. 12(6). 499–506. 93 indexed citations

Ngaimisi, Eliford, Sabina Mugusi, Omary Minzi, et al.. (2011). Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis. Clinical Pharmacology & Therapeutics. 90(3). 406–413. 66 indexed citations

Gotō, Naoki, Reiji Yoshimura, Shingo Kakeda, et al.. (2010). Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls. European Psychiatry. 26(1). 57–63. 20 indexed citations

Ngaimisi, Eliford, Sabina Mugusi, Omary Minzi, et al.. (2010). Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients. Clinical Pharmacology & Therapeutics. 88(5). 676–684. 92 indexed citations

Yoshimura, Reiji, Akira Tamagawa, Takashi Uozumi, et al.. (2006). High-Frequency Repetitive Transcranial Magnetic Stimulation Improves Refractory Depression by Influencing Catecholamine and Brain-Derived Neurotrophic Factors. Pharmacopsychiatry. 39(2). 52–59. 120 indexed citations

10.

Terao, Takeshi, Hideki Kojima, Yoshiaki Inoue, et al.. (2004). A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests. Psychopharmacology. 176(3-4). 407–411. 14 indexed citations

11.

Kojima, Hideki, Takeshi Terao, Naoki Inoue, et al.. (2003). Paroxetine as a 5-HT neuroendocrine probe. Psychopharmacology. 167(1). 97–102. 16 indexed citations

12.

Ueda, N., Reiji Yoshimura, Koji Shinkai, & Jun Nakamura. (2002). Plasma Levels of Catecholamine Metabolites Predict the Response to Sulpiride or Fluvoxamine in Major Depression. Pharmacopsychiatry. 35(5). 175–181. 36 indexed citations

13.

Nakamura, Jun, Reiji Yoshimura, Tadao Okuno, et al.. (2001). Association of plasma free-3-methoxy-4-hydroxyphenyl (ethylene)glycol, natural killer cell activity and delirium in postoperative patients. International Clinical Psychopharmacology. 16(6). 339–343. 11 indexed citations

14.

Yoshimura, Reiji, et al.. (2000). Low dosage of levomepromazine did not increase plasma concentrations of fluvoxamine. International Clinical Psychopharmacology. 15(4). 233–235. 5 indexed citations

15.

Yoshimura, Reiji, et al.. (2000). Effect of risperidone on plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG) levels in schizophrenic patients: relationship among plasma concentrations of risperidone and 9-hydroxyrisperidone, pMHPG levels, and clinical improvement. International Clinical Psychopharmacology. 15(3). 175–180. 34 indexed citations

16.

Hashimoto, Takashi, T. Suzuki, Tsukasa Nakamura, et al.. (1998). ABO-incompatible living related liver transplantation for fulminant hepatitis: report of a successful pediatric case with long-term follow-up. Transplantation Proceedings. 30(7). 3510–3512. 4 indexed citations

17.

Ueda, N., et al.. (1998). Pharmacological and pharmacokinetic studies of the newly synthesized thiazolidinedione derivative 5-(4-(1-phenyl-1-cyclopropanecarbonylamino)benzyl)-thiazolidine-2 ,4-dio ne.. PubMed. 48(6). 651–7. 1 indexed citations

18.

Taguchi, T, et al.. (1992). [Co-operative clinical evaluation of 5'-DFUR tablets for breast cancer at 31 institutions].. PubMed. 19(7). 1041–8. 1 indexed citations

19.

Takai, Yoshiki, et al.. (1985). [A case of Krukenberg tumor associated with elevation in blood testosterone].. PubMed. 60(3). 440–4. 1 indexed citations

20.

Ueda, N.. (1982). [Atypical facial pain in neurotic depression].. PubMed. 91(12). 54, 57–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact